Patent application number | Description | Published |
20100231191 | Method and apparatus for simulating a potentiometer - Method and apparatus are disclosed for electronic simulation of a potentiometer, and for providing a potentiometric output voltage that is representative of a parameter. The invention also teaches a non-contact type of sensor apparatus producing an output voltage that is indicative of a value of a sensed physical parameter. Electrical characteristics of a potentiometer are simulated by implementing a novel combination of analog and digital circuit techniques. Some of these characteristics include low input current, wide power supply voltage range, and an output voltage range that includes the power supply voltages. The present invention also teaches a sensor comprising electronically simulated potentiometer circuitry and a non-contact sensing element. | 09-16-2010 |
20130088243 | POSITION SENSING HEAD WITH REDUNDANCY - A position sensing head combines a sensing element and a simplified electronic module to enable operation with one wire, in addition to a circuit common, for providing power and transmitting a signal, while separating the sensing head from signal conditioning circuits by over 10 meters. The simplicity of the electronic module allows the use of basic electronic components that operate at more than 225° C. The signal is a variable frequency impressed onto the one wire, which can be read by a frequency meter. Another signal, such as a position or temperature, can be impressed onto the one wire at the same time as the first signal. The second signal is of a different frequency range so that it will not interfere with the first. A demodulator circuit can separate the two signals. The sensing element construction allows for locating up to three active elements measuring the same target. | 04-11-2013 |
20140266162 | POSITION SENSOR WITH IMPROVED SIGNAL TO NOISE RATIO - A magnetostrictive position sensor achieves an improved signal to noise ratio by implementing several electronic control features, including: enclosing a waveguide within an approximately tubular return conductor, adjusting the energy of an interrogation pulse and then clamping the waveguide, tracking the peak voltage of a sensed signal, cutting off the signal of a pickup during the time period outside of a signal time frame, adjusting the pass band of a filter based on an interrogation rate and waveguide length, zeroing and scaling a signal without digitizing the signal, and avoiding noise from an interrogation voltage generator. | 09-18-2014 |
Patent application number | Description | Published |
20120041246 | NANOWIRE CATALYSTS - Nanowires useful as heterogeneous catalysts are provided. The nanowire catalysts are useful in a variety of catalytic reactions, for example, the oxidative coupling of methane to ethylene. Related methods for use and manufacture of the same are also disclosed. | 02-16-2012 |
20130023709 | CATALYSTS FOR PETROCHEMICAL CATALYSIS - Metal oxide catalysts comprising various dopants are provided. The catalysts are useful as heterogenous catalysts in a variety of catalytic reactions, for example, the oxidative coupling of methane to C2 hydrocarbons such as ethane and ethylene. Related methods for use and manufacture of the same are also disclosed. | 01-24-2013 |
20130158322 | POLYMER TEMPLATED NANOWIRE CATALYSTS - Nanowires useful as heterogeneous catalysts are provided. The nanowire catalysts are prepared by polymer templated methods and are useful in a variety of catalytic reactions, for example, the oxidative coupling of methane to ethane and/or ethylene. Related methods for use and manufacture of the same are also disclosed. | 06-20-2013 |
20130165728 | NANOWIRE CATALYSTS AND METHODS FOR THEIR USE AND PREPARATION - Nanowires useful as heterogeneous catalysts are provided. The nanowire catalysts are useful in a variety of catalytic reactions, for example, the oxidative coupling of methane to C2 hydrocarbons. Related methods for use and manufacture of the same are also disclosed. | 06-27-2013 |
20140121433 | CATALYTIC FORMS AND FORMULATIONS - Catalytic forms and formulations are provided. The catalytic forms and formulations are useful in a variety of catalytic reactions, for example, the oxidative coupling of methane. Related methods for use and manufacture of the same are also disclosed. | 05-01-2014 |
20140171707 | INTEGRATED PROCESSES AND SYSTEMS FOR CONVERSION OF METHANE TO MULTIPLE HIGHER HYDROCARBON PRODUCTS - Integrated systems are provided for the production of higher hydrocarbon compositions, for example liquid hydrocarbon compositions, from methane using an oxidative coupling of methane system to convert methane to ethylene, followed by conversion of ethylene to selectable higher hydrocarbon products. Integrated systems and processes are provided that process methane through to these higher hydrocarbon products. | 06-19-2014 |
20140274671 | CATALYSTS FOR PETROCHEMICAL CATALYSIS - Metal oxide catalysts comprising various dopants are provided. The catalysts are useful as heterogenous catalysts in a variety of catalytic reactions, for example, the oxidative coupling of methane to C2 hydrocarbons such as ethane and ethylene. Related methods for use and manufacture of the same are also disclosed. | 09-18-2014 |
20150073192 | CATALYSTS FOR PETROCHEMICAL CATALYSIS - Metal oxide catalysts comprising various dopants are provided. The catalysts are useful as heterogenous catalysts in a variety of catalytic reactions, for example, the oxidative coupling of methane to C2 hydrocarbons such as ethane and ethylene. Related methods for use and manufacture of the same are also disclosed. | 03-12-2015 |
20150087875 | NANOWIRE CATALYSTS AND METHODS FOR THEIR USE AND PREPARATION - Nanowires useful as heterogeneous catalysts are provided. The nanowire catalysts are useful in a variety of catalytic reactions, for example, the oxidative coupling of methane to C2 hydrocarbons. Related methods for use and manufacture of the same are also disclosed. | 03-26-2015 |
Patent application number | Description | Published |
20080292709 | KITS FOR DHEA AND DHEA-SULFATE FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE - Kits for treating or preventing chronic obstructive pulmonary disease (COPD) by using as active agent a non-glucorticoid steroid, analogue thereof, such as dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEA-S), or their salts, in an amount effective for preventing or treating COPD. | 11-27-2008 |
20090053143 | LIQUID INHALATION FORMULATIONS OF DEHYDROEPIANDROSTERONE DERIVATIVES - Liquid pharmaceutical compositions and kits for administration to the lungs comprise a carrier and an agent for the treatment of bronchoconstriction and asthma, wherein the agent comprises a derivative of dehydroepiandrosterone having an SO2H or SO2Na group. The liquid formulations can be administered as an aerosol. | 02-26-2009 |
20090054385 | SOLID INHALATION FORMULATIONS OF DEHYDROEPIANDROSTERONE DERIVATIVES - Solid pharmaceutical compositions and kits for administration to the lungs comprise a carrier and an agent for the treatment of bronchoconstriction and asthma, wherein the agent comprises a derivative of dehydroepiandrosterone having an SO2H or SO2Na group. The solid formulations can be administered as an aerosol. | 02-26-2009 |
20090258046 | COMPOSITION, FORMULATIONS AND KIT FOR TREATMENT OF RESPIRATORY AND LUNG DISEASE WITH NON-GLUCOCORTICOID STEROIDS AND/OR UBIQUINONE AND A BRONCHODILATING AGENT - A pharmaceutical or veterinary composition, which comprises a first active agent selected from a non-glucocorticoid steroid or analogues, a ubiquinone, or salts thereof, and a second active agent comprising a bronchodilator. The composition is provided in various formulations and in the form of a kit. The products of this patent are applied to the prophylaxis and treatment of respiratory, lung and malignant diseases. | 10-15-2009 |
20110045032 | COMPOSITION, FORMULATIONS & KIT FOR TREATMENT OF RESPIRATORY AND LUNG DISEASE WITH DEHYDROEPIANDROSTERONE(S) STEROID & AN ANTI-MUSCARINIC AGENT(S) - A pharmaceutical or veterinary composition comprises a non-corticosteroids, and/or salts thereof, and an anti-muscarinic (anti-cholinergic) agent, and/or pharmaceutically or veterinarily acceptable salts thereof. The composition is provided in various formulations and in the form of a kit. The products of this patent are useful in the prophylaxis and treatment of various respiratory, lung and malignant diseases. | 02-24-2011 |
Patent application number | Description | Published |
20110178069 | INHIBITORS OF INTERLEUKIN-1 BETA CONVERTING ENZYME - The present invention relates to novel classes of compounds which are inhibitors of interleukin-1β converting enzyme. The ICE inhibitors of this invention are characterized by specific structural and physicochemical features. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting ICE activity and consequently, may be advantageously used as agents against IL-1-, apoptosis-, IGIF-, and IFN-γ-mediated diseases, inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, degenerative diseases, and necrotic diseases. This invention also relates to methods for inhibiting ICE activity, for treating interleukin-1-, apoptosis-, IGIF- and IFN-γ-mediated diseases and decreasing IGIF and IFN-γ production using the compounds and compositions of this invention. This invention also relates to methods for preparing N-acylamino compounds. | 07-21-2011 |
20120165319 | INHIBITORS OF INTERLEUKIN-1 BETA CONVERTING ENZYME - The present invention relates to novel classes of compounds which are inhibitors of interleukin-1β converting enzyme. The ICE inhibitors of this invention are characterized by specific structural and physicochemical features. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting ICE activity and consequently, may be advantageously used as agents against IL-1-, apoptosis-, IGIF-, and IFN-γ-mediated diseases, inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, degenerative diseases, and necrotic diseases. This invention also relates to methods for inhibiting ICE activity, for treating interleukin-1-, apoptosis-, IGIF- and IFN-γ-mediated diseases and decreasing IGIF and IFN-γ production using the compounds and compositions of this invention. This invention also relates to methods for preparing N-acylamino compounds. | 06-28-2012 |